Oxigene (OXGN) expands its zybrestat patient program with Azanta A/S to include the additional...

|By:, SA News Editor

Oxigene (OXGN) expands its zybrestat patient program with Azanta A/S to include the additional territories of Israel and South Korea, thus expanding on its existing regions consisting of the European Union, the Nordic countries, Switzerland, and Canada. Under the terms of the agreement, OXGN will provide Zybrestat to Azanta, and Azanta then serves as the exclusive distributor in the specified territory.